Netherlands· NL-e4b890eea279
Qutenza 179 mg, Huidpleister
A capsaicin product containing capsaicine, registered in Netherlands by Grunenthal GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Capsaicin is registered in 12 of 19 countries.
Countries holding a registration under ATC N01BX04 (capsaicin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Capsaicin · ATC N01BX04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CAPSAICINE
- Manufacturer
- Grunenthal GmbH
- Country
- Netherlands (NL)
- ATC code
- N01BX04
- ATC class
- Capsaicin
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/09/524
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Capsaicin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandQutenzaParanova Oy
- SpainQUTENZA 179 mg PARCHE CUTANEOGrünenthal Gmbh
- FranceQUTENZA 179 mg, patch cutanéGRUNENTHAL
- United KingdomQutenza 179mg cutaneous patchesGrunenthal Ltd
- IrelandQutenza 179 mg cutaneous patchGrünenthal GmbH
- IcelandQutenzaGrünenthal GmbH*
- NorwayQutenzaGrünenthal GmbH (1)
- BelgiumQutenza 179 mgGrünenthal
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Abc Lokale Schmerz-Therapie Wärme
- Germany · Abc Lokale Schmerz-Therapie Wärme
- Spain · Alacapsin, Capsicin
- United Kingdom (Northern Ireland) · Axsain, Capsaicin Ennogen Ip
- Greece · Capsaxin, Capser
- Ireland · Axsain, Zacin
- Iceland · Capsina, Qutenza
- Liechtenstein · Qutenza
- Norway · Capsina, Qutenza
- Portugal · Neodor
- Sweden · Capsina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe34e374-8efa-4558-9885-40c6761bcc4d GET /v1/drugs/fe34e374-8efa-4558-9885-40c6761bcc4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pleister",
"route": "Cutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/qutenza-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Capsaicin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp101241",
"excipients": [
"BUTYLHYDROXYANISOL (E 320)",
"CARBOMEER 1382",
"COPOLYMEER VAN POLY(DIMETHYLSILOXAAN-HYDROXIDE)(19,9)-TRIMETHYLSILYLSILICAATHARS(43,5)-HEXAMETHYLDISILAZAAN(9,9)",
"COPOLYMEER VAN POLY(DIMETHYLSILOXAAN-HYDROXIDE)(22,6)-TRIMETHYLSILYLSILICAATHARS(38,6)-HEXAMETHYLDISILAZAAN(11,3)",
"DIETHYLEENGLYCOLMONOETHYLETHER",
"DINATRIUMEDETAAT 2-WATER",
"ETHYLCELLULOSE (E 462)",
"MACROGOL 300",
"NATRIUMHYDROXIDE (E 524)",
"POLYESTERFILM, GEFLUORIDEERD",
"POLYETHYLEENTEREPHTHALAAT, GESILICONEERD",
"SILICONENOLIE",
"WATER, GEZUIVERD"
],
"substances": [
"CAPSAICINE"
],
"leaflet_url": null,
"authorised_at": "2009/05/15",
"procedure_number": "EMEA/H/C/000909",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/09/524",
"additional_monitoring": "N"
}See everything about capsaicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.